Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06699680 · ClinicalTrials.gov registry record · Phase 1
Phase 1 Study of PRX019 in Healthy Adult Volunteers
A Phase 1 study of Healthy Participants Study, sponsored by Prothena Biosciences.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06699680: Recruiting Phase 1 study of Healthy Participants Study, sponsored by Prothena Biosciences.
NCT06699680 is a Phase 1 study of Healthy Participants Study that is actively recruiting participants, run by Prothena Biosciences. The registered enrollment target is 48 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06699680, a Phase 1 study of Healthy Participants Study, is actively recruiting participants, sponsored by Prothena Biosciences.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the safety and tolerability of PRX019 in healthy adult participants.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG PRX019
Study Locations (1)
California
- Local Institution - Los Alamitos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-11-08 |
| Est. Completion | 2026-01-23 |
| Phase | Phase 1 |
What NCT06699680 shows while recruiting
NCT06699680 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (20% lower).
The record links to 1 condition, with Healthy Participants Study appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06699680 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06699680 about?
NCT06699680 is a clinical study titled "Phase 1 Study of PRX019 in Healthy Adult Volunteers". The purpose of this study is to assess the safety and tolerability of PRX019 in healthy adult participants.
What is the current status of trial NCT06699680?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2024-11-08. Estimated completion is 2026-01-23.
What conditions does trial NCT06699680 study?
This clinical trial studies the following conditions: Healthy Participants Study.
What interventions are being tested in trial NCT06699680?
The interventions under investigation include: Placebo (DRUG), PRX019 (DRUG).
Who is sponsoring clinical trial NCT06699680?
This trial is sponsored by Prothena Biosciences, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06699680 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06699680's enrollment target sits among peer trials
48 1026th of 2000 higher than 948 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI